Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma

被引:7
作者
Agirre-Lizaso, Alona [1 ]
Huici-Izagirre, Maider [1 ]
Urretabizkaia-Garmendia, Josu [1 ]
Rodrigues, Pedro M. [1 ,2 ,3 ]
Banales, Jesus M. [1 ,2 ,3 ,4 ]
Perugorria, Maria J. [1 ,2 ,5 ]
机构
[1] Univ Basque Country, Donostia Univ Hosp, Biodonostia Res Inst, Dept Liver & Gastrointestinal Dis,UPV EHU, Donostia San Sebastian 20014, Spain
[2] Inst Salud Carlos III ISCIII, Ctr Study Liver & Gastrointestinal Dis CIBERehd, Madrid 28029, Spain
[3] Basque Fdn Sci, IKERBASQUE, Bilbao 48009, Spain
[4] Univ Navarra, Sch Sci, Dept Biochem & Genet, Pamplona 31008, Spain
[5] Univ Basque Country, Fac Med & Nursing, Dept Med, UPV EHU, Donostia San Sebastian 20014, Spain
关键词
liver cancer; hepatocellular carcinoma; immunotherapy; tumour microenvironment; tumour-associated macrophages; innate immune system; macrophage reprogramming; EPITHELIAL-MESENCHYMAL TRANSITION; LIVER MACROPHAGES; DOUBLE-BLIND; C/EBP-ALPHA; CELLS; SORAFENIB; PROMOTE; GROWTH; MICROENVIRONMENT; POLARIZATION;
D O I
10.3390/cancers15204977
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Hepatocellular carcinoma (HCC) is a highly lethal disease with an increasing incidence. Despite the advancements in diagnosis and recent therapeutic options, improving the prognosis of HCC patients remains challenging. One of the reasons of the unsatisfactory outcome of patients with HCC is the complex tumour microenvironment (TME), which is composed of immune and stromal cells, limiting effective treatments. Recent research has highlighted the importance of macrophages in the development and progression of HCC, opening new possibilities for therapy. This review focuses on the heterogeneity of tumour-associated macrophages (TAMs) in HCC, the mechanisms through which HCC tumour cells polarize macrophages, and the therapeutic targets that are currently being tested to explore novel therapies that can improve the prognosis and quality of life of HCC patients.Abstract Hepatocellular carcinoma (HCC) is a prevalent and aggressive cancer that comprises a complex tumour microenvironment (TME). Tumour-associated macrophages (TAMs) are one of the most abundant immune cells present in the TME, and play a key role both in the development and in the progression of HCC. Thus, TAM-based immunotherapy has been presented as a promising strategy to complement the currently available therapies for HCC treatment. Among the novel approaches focusing on TAMs, reprogramming their functional state has emerged as a promising option for targeting TAMs as an immunotherapy in combination with the currently available treatment options. Nevertheless, a further understanding of the immunobiology of TAMs is still required. This review synthesizes current insights into the heterogeneous nature of TAMs in HCC and describes the mechanisms behind their pro-tumoural polarization focusing the attention on their interaction with HCC cells. Furthermore, this review underscores the potential involvement of TAMs' reprogramming in HCC therapy and highlights the urgency of advancing our understanding of these cells within the dynamic landscape of HCC.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
    Coscia, Marta
    Quaglino, Elena
    Iezzi, Manuela
    Curcio, Claudia
    Pantaleoni, Francesca
    Riganti, Chiara
    Holen, Ingunn
    Monkkonen, Hannu
    Boccadoro, Mario
    Forni, Guido
    Musiani, Piero
    Bosia, Amalia
    Cavallo, Federica
    Massaia, Massimo
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (12) : 2803 - 2815
  • [22] Cathepsin L promotes oesophageal squamous cell carcinoma development and may be associated with tumour-associated macrophages
    Zhang, Zhenhu
    Wang, Jianyu
    Shi, Yamin
    Wang, Ben
    Wang, Dong
    HELIYON, 2024, 10 (07)
  • [23] Natural compounds modulate the mechanism of action of tumour-associated macrophages against colorectal cancer: a review
    Yuan, Weichen
    Zhang, Jiexiang
    Chen, Haibin
    Zhuang, Yupei
    Zhou, Hongli
    Li, Wenting
    Qiu, Wenli
    Zhou, Hongguang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (11)
  • [24] Nanoparticle formulation of mycophenolate mofetil achieves enhanced efficacy against hepatocellular carcinoma by targeting tumour-associated fibroblast
    Yang, Zhentao
    Zhang, Liang
    Zhu, Hai
    Zhou, Ke
    Wang, Hangxiang
    Wang, Yuchen
    Su, Rong
    Guo, Danjing
    Zhou, Lin
    Xu, Xiao
    Song, Penghong
    Zheng, Shusen
    Xie, Haiyang
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (07) : 3511 - 3523
  • [25] The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology
    Vanmeerbeek, Isaure
    Govaerts, Jannes
    Laureano, Raquel S.
    Sprooten, Jenny
    Naulaerts, Stefan
    Borras, Daniel M.
    Laoui, Damya
    Mazzone, Massimiliano
    Van Ginderachter, Jo A.
    Garg, Abhishek D.
    CELLS, 2022, 11 (23)
  • [26] Bacterial-Mediated In Situ Engineering of Tumour-Associated Macrophages for Cancer Immunotherapy
    Kuhl, Gabriela Christina
    Tangney, Mark
    CANCERS, 2025, 17 (05)
  • [27] Prognostic value and clinicopathological roles of phenotypes of tumour-associated macrophages in colorectal cancer
    Zhao, Yamei
    Ge, Xiaoxu
    Xu, Xiaoming
    Yu, Shaojun
    Wang, Jian
    Sun, Lifeng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (12) : 3005 - 3019
  • [28] Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
    Colegio, Oscar R.
    Ngoc-Quynh Chu
    Szabo, Alison L.
    Chu, Thach
    Rhebergen, Anne Marie
    Jairam, Vikram
    Cyrus, Nika
    Brokowski, Carolyn E.
    Eisenbarth, Stephanie C.
    Phillips, Gillian M.
    Cline, Gary W.
    Phillips, Andrew J.
    Medzhitov, Ruslan
    NATURE, 2014, 513 (7519) : 559 - +
  • [29] Tumour-associated macrophages correlate with microvascular bed extension in colorectal cancer patients
    Marech, Ilaria
    Ammendola, Michele
    Sacco, Rosario
    Sammarco, Giuseppe
    Zuccala, Valeria
    Zizzo, Nicola
    Leporini, Christian
    Luposella, Maria
    Patruno, Rosa
    Filippelli, Gianfranco
    Russo, Emilio
    Porcelli, Mariangela
    Gadaleta, Cosmo Damiano
    De Sarro, Giovambattista
    Ranieri, Girolamo
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (07) : 1373 - 1380
  • [30] Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models
    Belgiovine, Cristina
    Bello, Ezia
    Liguori, Manuela
    Craparotta, Ilaria
    Mannarino, Laura
    Paracchini, Lara
    Beltrame, Luca
    Marchini, Sergio
    Galmarini, Carlos M.
    Mantovani, Alberto
    Frapolli, Roberta
    Allavena, Paola
    D'Incalci, Maurizio
    BRITISH JOURNAL OF CANCER, 2017, 117 (05) : 628 - 638